glp-1 use in type 1 diabetes More people with are using drugs, study finds, despite limited evidence on safety or effectiveness Improved Heart and Kidney Outcomes
Description
Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

Five things you should know about using GLP-1 drugs for weight loss

Andy's journey to GLP-1s: Although he was reluctant

Lipid Panel Provides insights on your cholesterol levels, including Total Cholesterol, LDL, HDL, and Triglycerides
